Penn scientists demonstrate potential of graphene films as next-generation t... ( PHILADELPHIA

Penn scientists demonstrate potential of graphene films as next-generation transistors

Date:7/31/2008

PHILADELPHIA - Physicists at the University of Pennsylvania have characterized an aspect of graphene film behavior by measuring the way it conducts electricity on a substrate. This milestone advances the potential application of graphene, the ultra-thin, single-atom thick carbon sheets that conduct electricity faster and more efficiently than silicon, the current material of choice for transistor fabrication.

The research team, led by A.T. Charlie Johnson, professor in the Department of Physics and Astronomy at Penn, demonstrated that the surface potential above a graphene film varies with the thickness of the film, in quantitative agreement with the predictions of a nonlinear Thomas-Fermi theory of the interlayer screening by relativistic low energy charge carriers. The study appears online in the journal Nano Letters and will appear in print in the August edition.

Johnson's study, "Surface Potentials and Layer Charge Distributions in Few-Layer Graphene Films," clarifies experimentally the electronic interaction between an insulating substrate and few-layer graphene films, or FLGs, the standard model for next-generation transistors.

It is more practical to develop devices from FLGs, rather than single-layer materials. To make use of these films, graphene must be placed on a substrate to be functionalized as a transistor. Placing the film on a substrate causes an electronic interaction between the two materials that transfers carriers to or from, or "dopes," the FLG.

The focus of the Penn study was aimed at understanding how these doped charges distribute themselves among the different layers of graphene. The distribution of these charges determines the behavior of graphene transistors and other circuits, making it a critical component for device engineering. The team measured the surface potential of the material to determine how these doped charges were distributed along the transistor, as well as how the
'/>"/>

Contact: Jordan Reese
jreese@upenn.edu
215-573-6604
University of Pennsylvania
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related biology technology :

1. Scientists demonstrate highly directional semiconductor lasers
2. Conference to Turn Scientists of Color into PA-Based Entrepreneurs Set for November
3. Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science
4. Virtual world is sign of future for scientists, engineers
5. Scientists fix bugs in our understanding of evolution
6. Ten Latin American Scientists Named 2008 Pew Fellows in the Biomedical Sciences
7. Israeli Scientists Recipients of 2008 International Adult Stem Cell Award
8. Weizmann Institute scientists create new nanotube structures
9. Abbott Scientists Present a New Approach for Treating Attention-Deficit Hyperactivity Disorder
10. Leading Overseas Scientists Establish High-Tech Bio-Pharmaceutical Enterprise in Changzhou
11. Scientists call for more access to biotech crop data

Post Your Comments:

(Date:2/9/2010)... Belgium , February 9 /PRNewswire-FirstCall/ ... Examines the Potential of Microplasmin to Improve the ... Diseases ,, ThromboGenics NV ... discovery and development of innovative treatments for eye,disease, ... positive,microplasmin Phase II trial results, evaluating the product,s ...

(Date:2/8/2010)... MISSISSAUGA, ON , Feb. 8 /PRNewswire-FirstCall/ ... YM), today reported operational and financial results for ... December 31, 2009 . ,, "After rigorous evaluation ... merge Cytopia Limited., a clinical-stage, Melbourne -based ... quarter," said David Allan , Chairman & ...

(Date:2/8/2010)... CMED ), a leading China -based advanced in-vitro,diagnostic ("IVD") company, today announced that it will ... Conference Date ... Renshaw Annual March 7-9, 2010 The Regent ... ... Credit Suisse Asian March 22-26, ...

(Date:2/8/2010)... five months ahead of schedule ,, TSX Exchange Symbol: ... Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today ... clinical study of its lead drug RVX-208. "The completion ... full 5 months ahead of our original schedule, is ... collaborators at the Cleveland Clinic. At this rate we ...

[0] ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology [0] YM BioSciences reports second quarter 2010 operational and financial results [0] China Medical Technologies to Participate Investor Conferences in March 2010 [0] Resverlogix Completes Patient Recruitment for ASSERT Trial

... July 17 Following intense,speculation in sections ... Daiichi Sankyo,Company, Limited (TSE: 4568.JP) ("Daiichi Sankyo") ... that the agreement,between Daiichi Sankyo, Ranbaxy and ... Ranbaxy, is binding and final, subject to,regulatory ...

... Supply Solutions(R),a focus area within SAFC(R), a ... today that the Company has launched a ... with their regulatory,requirement under the new European ... Authorization and restriction of Chemicals,(REACH) http://www.safcsupplysolutions.com/reach ...

... have combined the efforts of two kinds of bacteria to ... providing food for the other. According to an article in ... has an added bonus: leftover enzymes can be used to ... fuel cells that convert hydrogen into energy. , Hydrogen has ...

Other Biology Technology:Daiichi Sankyo and Ranbaxy Confirm Deal Is Binding and Final, Allay Market Rumour and Speculation 2 SAFC Supply Solutions Launches REACH-Compliant Products and Support 2 SAFC Supply Solutions Launches REACH-Compliant Products and Support 3 Fuel from food waste: bacteria provide power 2

Daiichi Sankyo and Ranbaxy Confirm Deal Is Binding and Final, Allay Market Rumour and Speculation SAFC Supply Solutions Launches REACH-Compliant Products and Support Fuel from food waste: bacteria provide power

(Date:2/8/2010)... February 9, 2010 Cellular imaging offers a wealth ... harnessing this technique to study biological systems is a ... Genome Research ( www.genome.org ), researchers have ... images to identify genetic interactions within biological networks, offering ... analysis. , For years, scientists have been peering through ...

(Date:2/8/2010)... The nation,s first fully integrated collaboration ... improve health and reduce healthcare spending has been ... . The Full Yield rolls out in greater ... exclusive partnership with Harvard Pilgrim Health Care ... the U.S., and an inaugural partnership with ...

(Date:2/7/2010)... habits or behaviors, like cigarette smoking, may influence the ... HPV. , According to survey results on correlates ... vaccinate their daughters was not associated with one,s background ... certain behavioral factors of the parents. , Results of ... Cancer Epidemiology, Biomarkers & Prevention , a journal ...

[0] Method of the future uses single-cell imaging to identify gene interactions [0] The Full Yield, Inc. Launches Breakthrough Collaboration to Put Food Back at the Heart of Healthcare [0] More smokers than non-smokers accept HPV vaccination for their daughters

... is a life-threatening disease caused by exposure to botulinum ... These neurotoxins are produced by Clostridium botulinum, a bacterium ... toxins bind to and enter neurons, interfering with nerve ... muscle fibers throughout the body. Poisoning with botulinum toxins ...

... outcome from traditional radiation and chemotherapy treatment for head ... a good prognosis with treatment of p53 tumor suppressor ... biomarker test for a gene-based drug. , Researchers at ... with advanced squamous cell carcinoma of the head and ...

... Library of Science (PLoS) announced today the creation ... access journal devoted to the world's most neglected ... ) will focus on the overlooked diseases that ... countries, including elephantiasis, river blindness, leprosy, hookworm, schistosomiasis, ...

Other Biology News:Abnormal overexpression of p53 is a predictive molecular biomarker 2 Public Library of Science to launch new, open access journal on neglected tropical diseases 2 Public Library of Science to launch new, open access journal on neglected tropical diseases 3

Molecular structure reveals how botulinum toxin attaches to nerve cells Abnormal overexpression of p53 is a predictive molecular biomarker Public Library of Science to launch new, open access journal on neglected tropical diseases

Assay Diluent Trial Pack, 4 x 100 mL...

... Immunogen: Synthetic peptide derived from ... junctophilin-3. Specificity: Specific for the ... Reactivity: Mouse (positive controls: mouse ... heart tissues). Applications: Western blotting ...

Rabbit anti-Junctophilin-4 (C-term)...

SpectroQuest single beam 4nm UV/Vis spectrophotometer; stand-alone unit; large angled LCD screen; large sample compartment...

Biology Products:

Assay Diluent Trial Pack from BioFX Laboratories, Inc.Rabbit Anti-Mouse Junctophilin-3 (Mid) Monoclonal Antibody, Clone ZMD.474 from Invitrogen Rabbit Anti-Mouse Junctophilin-4, C-Terminus Monoclonal Antibody, Unconjugated, Clone PADZMD.487 from Invitrogen UNICO Spectrophotometer from Femto Scientific

Penn scientists demonstrate potential of graphene films as next-generation t...( PHILADELPHIA - Physicists at the U...)